Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.
Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Orlando, FL, USA.
Oncogene. 2014 Jan 2;33(1):10-8. doi: 10.1038/onc.2012.545. Epub 2012 Dec 10.
We have previously demonstrated that Krüppel-like factor 8 (KLF8) participates in oncogenic transformation of mouse fibroblasts and is highly overexpressed in human ovarian cancer. In this work, we first correlated KLF8 overexpression with the aggressiveness of ovarian patient tumors and then tested if KLF8 could transform human ovarian epithelial cells. Using the immortalized non-tumorigenic human ovarian surface epithelial cell line T80 and retroviral infection, we generated cell lines that constitutively overexpress KLF8 alone or its combination with the known ovarian oncogenes c-Myc, Stat3c and/or Akt and examined the cell lines for anchorage-independent growth and tumorigenesis. The soft agar clonogenic assay showed that T80/KLF8 cells formed significantly more colonies than the mock cells. Interestingly, the cells expressing both KLF8 and c-Myc formed the largest amounts of colonies, greater than the sum of colonies formed by the cells expressing KLF8 and c-Myc alone. These results suggested that KLF8 might be a weak oncogene that works cooperatively with c-Myc to transform ovarian cells. Surprisingly, overexpression of KLF8 alone was sufficient to induce tumorigenesis in nude mice resulting in short lifespan irrespective of whether the T80/KLF8 cells were injected subcutaneously, intraperitoneally or orthotopically into the ovarian bursa. Histopathological studies confirmed that the T80/KLF8 tumors were characteristic of human serous ovarian carcinomas. Comparative expression profiling and functional studies identified the cell cycle regulators cyclin D1 and USP44 as primary KLF8 targets and effectors for the T80 transformation. Overall, we identified KLF8 overexpression as an important factor in human ovarian carcinoma pathogenesis.
我们之前已经证明,Krüppel 样因子 8(KLF8)参与了小鼠成纤维细胞的致癌转化,并且在人类卵巢癌中高度过表达。在这项工作中,我们首先将 KLF8 的过表达与卵巢患者肿瘤的侵袭性相关联,然后测试 KLF8 是否可以转化人类卵巢上皮细胞。我们使用永生化的非肿瘤性人类卵巢表面上皮细胞系 T80 和逆转录病毒感染,生成单独过表达 KLF8 或其与已知卵巢癌基因 c-Myc、Stat3c 和/或 Akt 组合的细胞系,并检查这些细胞系的非锚定依赖性生长和致瘤性。软琼脂集落形成实验表明,T80/KLF8 细胞比对照细胞形成的集落显著更多。有趣的是,表达 KLF8 和 c-Myc 的细胞形成的集落最多,超过了单独表达 KLF8 和 c-Myc 的细胞形成的集落的总和。这些结果表明,KLF8 可能是一种弱癌基因,与 c-Myc 合作转化卵巢细胞。令人惊讶的是,单独过表达 KLF8 足以在裸鼠中诱导肿瘤发生,导致寿命缩短,无论 T80/KLF8 细胞是皮下、腹腔内还是原位注射到卵巢囊中。组织病理学研究证实,T80/KLF8 肿瘤是人类浆液性卵巢癌的特征。比较表达谱和功能研究确定细胞周期调节剂 cyclin D1 和 USP44 为 KLF8 的主要靶标和 T80 转化的效应物。总体而言,我们确定 KLF8 的过表达是人类卵巢癌发病机制中的一个重要因素。